Navigation Links
First Telescopic Implant in Connecticut for Macular Degeneration

CHESHIRE, Conn., March 7, 2013 /PRNewswire-iReach/ -- Dr. Randolph Kinkade has been recently interviewed on WFSB's Your Health and WTNH's Health News discussing this new technology.  Dr. Kinkade, a Connecticut optometrist, is a founding member of the International Academy of Low Vision Specialists. 

About the size of an eraser tip, the Implantable Miniature Telescope shows promise for some patients who are legal blind due to macular degeneration.  Macular degeneration is the leading cause of permanent vision loss in older Americans. 

"I have been fitting Spectacle Miniature Telescopes in glasses for improving eyesight for over twenty years to help patients improve their ability to read, write and watch television", says Dr. Kinkade. "For certain patients we now have the ability to replace a developing cataract in their eye with a micro-telescope that returns some very useful vision."

The newly FDA and Medicare approved telescope is placed in only one eye.  The telescope implant focuses and enlarged image onto healthier parts of the macula and retina at the back of the eye.  The other eye provides the necessary peripheral or side vision for walking and performing other tasks.

Dr. Kinkade's treatment role is with candidate selection and determining which eye gets the implant.  He also spends considerable time with patients after surgery guiding them to use their new vision.  Dr. Mark Milner will be doing the surgery.

"The implant is not a cure for macular degeneration, but a rehabilitation tool to return some very important vision", says Dr. Kinkade.  "Patients will need to relearn to see and use additional low vision aids to maximize their vision."

For pictures of the telescopic implant, educational videos and information about the treatment program please visit

Dr. Kinkade office telephone is (800) 756-0766 and he can be emailed at

About Macular Degeneration

  • Macular degeneration affects the macula, the part of the retina needed for detail central vision. Patients do see things to the side with their peripheral vision, but it is too blurry for detailed vision like reading.
  • The first signs of macular degeneration may include wavy lines, distortion, or blurry spots when reading.
  • There are two types of macular degeneration (wet and dry).  There is no medical treatment for the dry form of the disease.
  • Low vision rehabilitation provides Spectacle Miniature Telescopes and other magnification aids to help restore lost vision.

Media Contact: Randolph Kinkade , OD, MPH, Low Vision Consulting, (800) 756-0766,

News distributed by PR Newswire iReach:

SOURCE Low Vision Consulting
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
2. Thoratec Schedules First Quarter Conference Call, Webcast
3. Watson to Host Conference Call and Webcast to Discuss First Quarter 2012 Earnings
4. CVS Caremark Corporation to Hold First Quarter 2012 Conference Call
5. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
6. Alexza to Announce 2012 First Quarter Financial Results on Thursday, May 10, 2012
7. 3SBio Inc. Schedules Unaudited First Quarter 2012 Results
8. Insmed to Host 2012 First Quarter Earnings Conference Call
9. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
10. Henry Schein to Webcast First Quarter 2012 Conference Call Tuesday, May 8, at 10:00 a.m. EDT
11. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
Post Your Comments:
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
(Date:9/19/2017)... medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed sound energy ... ... Jim Bertolina, PhD ... Tom Tefft ... executive Josh Stopek , PhD, who has led R&D and business development teams at ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family Medicine's ... President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. ... 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming the role ...
(Date:10/13/2017)... ... ... Apple Rehab Shelton Lakes , which specializes in the delivery of sub-acute ... of a disaster drill on October 3rd. , Apple Rehab participated with the Shelton ... well as the Connecticut Long Term Care Mutual Aid Plan (LTC-MAP). The LTC-MAP ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
(Date:10/12/2017)... ... , ... The American College of Medical Informatics (ACMI) will present the 2017 ... Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is ... pioneer in the field of medical informatics, this prestigious award is presented to an ...
Breaking Medicine News(10 mins):